ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 696

Chronic Periaortitis With Thoracic Aorta Involvement: A New Subtype Of Large Vessel Vasculitis

Alessandra Palmisano1, Maria Letizia Urban2, Domenico Corradi3, Federico Alberici4, Carlo Salvarani5, Carlo Buzio1 and Augusto Vaglio6, 1Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy, 2Nephrology University of Parma, Parma, Italy, 3Pathology University of Parma, Parma, Italy, 4Department of Clinical Medicine, Nephrology and Health Sciences, University of Parma, Parma, Italy, 5Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 6Unit of Nephrology, University Hospital of Parma, Parma, Italy

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Fibroblasts and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s - Clinical Aspects and Therapeutics I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Chronic periaortitis (CP) is characterised by a fibroinflammatory tissue arising from the adventitia of the abdominal aorta and the iliac arteries and spreading into the surrounding retroperitoneum. CP is thought to have an autoimmune origin and to arise as a primary aortitis. Involvement of the thoracic aorta and its main branches has been anecdotally described. We analysed frequency and pattern of involvement of the large thoracic arteries in CP patients.

Methods: We studied 77 consecutive CP patients who had appropriate imaging studies to evaluate thoracic vessel involvement (chest contrast-enhanced CT/MRI, angio-CT/MRI, whole-body CT-PET). All patients underwent routine clinical assessment and laboratory tests.

Results: Twenty-eight patients (36.4%) showed thoracic vessel involvement: 21 had thoracic periaortitis, which surrounded an aneurysmal thoracic aorta in 6 cases and also involved the origin of the epiaortic vessels in 9 cases; 7 patients had thoracic aortic aneurysm without periaortitis. Analysis of demographic and clinical features in the groups with and without thoracic involvement showed, in the former, a higher female prevalence (M/F ratio 14/14 vs 39/10, P=0.010), a more advanced age at diagnosis [median(interquartile range) 64.5 (58.3-69.-5)  vs 56.0 (50-59) years, P=0.001], a higher frequency of constitutional symptoms (86% vs. 59%, P=0.021),  and a shorter relapse-free survival (log-rank P=0.025). 

Conclusion: Involvement of large thoracic arteries occurs in about one-third of CP patients. This subset of patients with systemic large vessel involvement shows distinct clinical features, such as a higher female prevalence, a higher age at diagnosis, and a higher frequency of systemic symptoms; in addition, patients with thoracic involvement tend to have a frequently relapsing course. These findings raise the question as to whether this CP subset represents a distinct form of large-vessel vasculitis.


Disclosure:

A. Palmisano,
None;

M. L. Urban,
None;

D. Corradi,
None;

F. Alberici,
None;

C. Salvarani,
None;

C. Buzio,
None;

A. Vaglio,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chronic-periaortitis-with-thoracic-aorta-involvement-a-new-subtype-of-large-vessel-vasculitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology